Short-Acting beta2-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6. Nannini LJ. Am J Respir Crit Care Med 2020;202:1324.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nannini LJ. Short-Acting beta2-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6. Am J Respir Crit Care Med 2020;202:1324.
PMID: 32687403